Well, I'm not sure Vyleesi was ever going to be a 'Golden Egg' that pushes them to the next tier of companies. However, it would have been the beginning to a revenue stream that is elusive to many R&D pharma companies. I have read a few things about the gag order, and I have no insight on what or why, but it does not give me any comfort what so ever (quite the contrary, like why do business under restriction?).
I was keeping a list of the different compounds they had in development and trying to compile the progress along with it.. However, my fridge flooded my house a few months back and it appears that my notebook was one of the casualties or maybe it was just thrown away...
There are several projects where they can put the money into, which have already been streamlined within their research system. All 'transitions' are quite costly and have to be perfected, developed, and presented. Its just overhead expense that was not needed at this time... Maybe office overhead needed to justify their jobs somehow... I only see them needing to do this for a possible 'infusion' of cash... which from past PR was NOT something they should have needed...
It is possible what you say. And it is evident that they are diluting shareholders under the guise that shareholders approved it. I can say for one thing, that the positive comments made in the past have proven very misleading to me. That alone can be construed as fraud if not corrected via a statement.
The beaten down share price after the 1st success and soon to be a 2nd revenue stream, reflects something shady... the lack of 'valuable' PR reflects something shady... The breach of gag-ordered distribution contract reflects something shady... The need of more revenue at this juncture via dilution also reflects something shady... What am I missing here?
I have not been on any shareholders meeting or conference calls, and cannot speak to the information given on those (only what I have read). But what I can say, is there seems to be ZERO communication about why the funds are so strained.... They are not operating like a company that just obtained enough funds to satisfy research needs thru 2021....?????????
